Eyenovia Inc.

12/03/2020 | Press release | Distributed by Public on 12/03/2020 06:06

Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to Initiate Phase 3 VISION Trial by Year End